These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36395492)

  • 1. Microinjection via the suprachoroidal space: a review of a novel mode of administration.
    Ciulla T; Yeh S
    Am J Manag Care; 2022 Nov; 28(13 Suppl):S243-S252. PubMed ID: 36395492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suprachoroidal triamcinolone acetonide injectable suspension for macular edema associated with noninfectious uveitis: an in-depth look at efficacy and safety.
    Yeh S; Ciulla T
    Am J Manag Care; 2023 Feb; 29(2 Suppl):S19-S28. PubMed ID: 36787524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions.
    Kansara VS; Hancock SE; Muya LW; Ciulla TA
    J Control Release; 2022 Sep; 349():1045-1051. PubMed ID: 35868358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema.
    Fung S; Syed YY
    Drugs; 2022 Sep; 82(13):1403-1410. PubMed ID: 36018461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suprachoroidal Injection of Triamcinolone Acetonide Suspension: Ocular Pharmacokinetics and Distribution in Rabbits Demonstrates High and Durable Levels in the Chorioretina.
    Muya L; Kansara V; Cavet ME; Ciulla T
    J Ocul Pharmacol Ther; 2022; 38(6):459-467. PubMed ID: 35404132
    [No Abstract]   [Full Text] [Related]  

  • 6. Triamcinolone acetonide injectable suspension for suprachoroidal use in the treatment of macular edema associated with uveitis.
    Thomas J; Kim L; Albini T; Yeh S
    Expert Rev Ophthalmol; 2022; 17(3):165-173. PubMed ID: 36060305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomechanics of suprachoroidal drug delivery: From benchtop to clinical investigation in ocular therapies.
    Hancock SE; Wan CR; Fisher NE; Andino RV; Ciulla TA
    Expert Opin Drug Deliv; 2021 Jun; 18(6):777-788. PubMed ID: 33393391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triamcinolone Acetonide Suprachoroidal Injectable Suspension for Uveitic Macular Edema: Integrated Analysis of Two Phase 3 Studies.
    Yeh S; Henry CR; Kapik B; Ciulla TA
    Ophthalmol Ther; 2023 Feb; 12(1):577-591. PubMed ID: 36399237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular drug delivery targeted by iontophoresis in the suprachoroidal space using a microneedle.
    Jung JH; Chiang B; Grossniklaus HE; Prausnitz MR
    J Control Release; 2018 May; 277():14-22. PubMed ID: 29505807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The suprachoroidal space as a route of administration to the posterior segment of the eye.
    Chiang B; Jung JH; Prausnitz MR
    Adv Drug Deliv Rev; 2018 Feb; 126():58-66. PubMed ID: 29545195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroidal Changes After Suprachoroidal Injection of Triamcinolone Acetonide in Eyes With Macular Edema Secondary to Retinal Vein Occlusion.
    Willoughby AS; Vuong VS; Cunefare D; Farsiu S; Noronha G; Danis RP; Yiu G
    Am J Ophthalmol; 2018 Feb; 186():144-151. PubMed ID: 29199012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Delivery via the Suprachoroidal Space for the Treatment of Retinal Diseases.
    Naftali Ben Haim L; Moisseiev E
    Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34206925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suprachoroidal Injection of Triamcinolone- Review of a Novel Treatment for Macular Edema Caused by Noninfectious Uveitis.
    Price KW; Albini TA; Yeh S
    US Ophthalmic Rev; 2020; 13(2):76-79. PubMed ID: 34322164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles.
    Gilger BC; Abarca EM; Salmon JH; Patel S
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2483-92. PubMed ID: 23532526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suprachoroidally injected pharmacological agents for the treatment of chorio-retinal diseases: a targeted approach.
    Habot-Wilner Z; Noronha G; Wykoff CC
    Acta Ophthalmol; 2019 Aug; 97(5):460-472. PubMed ID: 30702218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases.
    Wan CR; Muya L; Kansara V; Ciulla TA
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33671815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of suprachoroidal triamcinolone injection in horses with poorly responsive equine recurrent uveitis.
    Gagnon NA; Hartley C; Gilger BC
    Vet Ophthalmol; 2021 May; 24(3):308-312. PubMed ID: 33788369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting drug delivery within the suprachoroidal space.
    Jung JH; Chae JJ; Prausnitz MR
    Drug Discov Today; 2019 Aug; 24(8):1654-1659. PubMed ID: 30953867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suprachoroidal Space Alterations Following Delivery of Triamcinolone Acetonide: Post-Hoc Analysis of the Phase 1/2 HULK Study of Patients With Diabetic Macular Edema.
    Lampen SIR; Khurana RN; Noronha G; Brown DM; Wykoff CC
    Ophthalmic Surg Lasers Imaging Retina; 2018 Sep; 49(9):692-697. PubMed ID: 30222804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.